Latest News about KDNY
Recent news which mentions KDNY
Chinook Therapeutics Trial Pause: Unfortunate But Analyst Reassures No Damage To Value Drivers
April 11, 2023
Tickers
KDNY
From Benzinga
From Benzinga
Analyst Views Multiple Opportunities For Chinook To Thrive In Emerging Renal Markets, Sees More Than 100% Upside
March 01, 2023
From Benzinga
From Benzinga
Have A Look At William Blair's Top Biotech Picks For 2023
December 25, 2022
From Benzinga
Chinook Therapeutics's Return On Capital Employed Insights
December 22, 2022
Tickers
KDNY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
From Benzinga
7 Cheap Biotech Stocks to Buy Now
August 03, 2022
From InvestorPlace
From Benzinga
From Benzinga
88 Biggest Movers From Yesterday
May 26, 2022
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
May 25, 2022
From Benzinga
From Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
May 25, 2022
From Benzinga
From Benzinga
From Benzinga
71 Biggest Movers From Yesterday
May 20, 2022
From Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
May 19, 2022
From Benzinga
Chinook's Kidney Disease Candidate Continues To Show Rapid, Sustained Reductions In Biomarkers
May 19, 2022
Tickers
KDNY
From Benzinga
From Benzinga
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Wednesdays With Wedbush: Analyst Laura Chico On The State Of Biotech
December 29, 2021
From Benzinga
76 Biggest Movers From Yesterday
November 11, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.